0.06 - 0.06
0.06 - 0.24
2.78M / 3.59M (Avg.)
-1.55 | -0.04
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
259.50%
5Y CAGR of 259.50% while SMR.AX is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
67.41%
3Y revenue/share CAGR under 50% of SMR.AX's 252.74%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
336.60%
OCF/share CAGR of 336.60% while SMR.AX is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
2470.48%
OCF/share CAGR of 2470.48% while SMR.AX is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
1201.06%
3Y OCF/share CAGR at 50-75% of SMR.AX's 1880.13%. Martin Whitman would suspect weaker recent execution or product competitiveness.
346.20%
Below 50% of SMR.AX's 20068.50%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
581.91%
Net income/share CAGR of 581.91% while SMR.AX is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
1255.61%
3Y net income/share CAGR above 1.5x SMR.AX's 779.67%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
-90.46%
Negative equity/share CAGR over 10 years while SMR.AX stands at 2642.59%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
13786.42%
Equity/share CAGR of 13786.42% while SMR.AX is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
62.08%
Below 50% of SMR.AX's 388.24%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1938.37%
Our short-term dividend growth is positive while SMR.AX cut theirs. John Neff views it as a comparative advantage in shareholder returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.